These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11397839)

  • 1. McCune-Albright syndrome: growth hormone dynamics in pregnancy.
    Obuobie K; Mullik V; Jones C; John R; Rees AE; Davies JS; Scanlon MF; Lazarus JH
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2456-8. PubMed ID: 11397839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.
    Cuttler L; Jackson JA; Saeed uz-Zafar M; Levitsky LL; Mellinger RC; Frohman LA
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1148-54. PubMed ID: 2498385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Management of Patients With McCune-Albright Syndrome With GH Excess and Precocious Puberty: A Case Series and Literature Review.
    Zhai X; Duan L; Yao Y; Xing B; Deng K; Wang L; Feng F; Liang Z; You H; Yang H; Lu L; Chen S; Wang R; Pan H; Zhu H
    Front Endocrinol (Lausanne); 2021; 12():672394. PubMed ID: 34777239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone hypersecretion in a girl with McCune-Albright syndrome: comparison with controls and response to a dose of long-acting somatostatin analog.
    Feuillan PP; Jones J; Ross JL
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1357-60. PubMed ID: 7714111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. McCune-Albright syndrome and acromegaly: effects of hypothalamopituitary radiotherapy and/or pegvisomant in somatostatin analog-resistant patients.
    Galland F; Kamenicky P; Affres H; Reznik Y; Pontvert D; Le Bouc Y; Young J; Chanson P
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4957-61. PubMed ID: 16984995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
    Wiesli P; Zwimpfer C; Zapf J; Schmid C
    Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal diagnosis of GH hypersecretory states.
    Grottoli S; Gasco V; Ragazzoni F; Ghigo E
    J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated bone turnover in pregnant women with McCune-Albright syndrome.
    Osada H; Sakamoto R; Seki K; Sekiya S
    Gynecol Obstet Invest; 2005; 60(2):102-7. PubMed ID: 15860920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome.
    Akintoye SO; Chebli C; Booher S; Feuillan P; Kushner H; Leroith D; Cherman N; Bianco P; Wientroub S; Robey PG; Collins MT
    J Clin Endocrinol Metab; 2002 Nov; 87(11):5104-12. PubMed ID: 12414879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acromegaly and pregnancy: report of six new cases].
    Persechini ML; Gennero I; Grunenwald S; Vezzosi D; Bennet A; Caron P
    J Gynecol Obstet Biol Reprod (Paris); 2014 Nov; 43(9):704-12. PubMed ID: 24035359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. McCune-Albright syndrome and acromegaly: hormonal control with use of cabergoline and long-acting somatostatin--case report.
    Almeida JP; Albuquerque LA; Ferraz CL; Mota I; Gondim J; Ferraz TM
    Arq Bras Endocrinol Metabol; 2009 Feb; 53(1):102-6. PubMed ID: 19347192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting and solving the interference of pregnancy serum, in a GH immunometric assay.
    Dias ML; Vieira JG; Abucham J
    Growth Horm IGF Res; 2013; 23(1-2):13-8. PubMed ID: 23206731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegvisomant for the treatment of gsp-mediated growth hormone excess in patients with McCune-Albright syndrome.
    Akintoye SO; Kelly MH; Brillante B; Cherman N; Turner S; Butman JA; Robey PG; Collins MT
    J Clin Endocrinol Metab; 2006 Aug; 91(8):2960-6. PubMed ID: 16720661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone-Insulin-like growth factor 1 axis hyperactivity on bone fibrous dysplasia in McCune-Albright Syndrome.
    Tessaris D; Boyce AM; Zacharin M; Matarazzo P; Lala R; De Sanctis L; Collins MT
    Clin Endocrinol (Oxf); 2018 Jul; 89(1):56-64. PubMed ID: 29672904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppressed levels of growth hormone and insulin-like growth factor-1 during successful pregnancy in persistent acromegaly.
    Shimatsu A; Usui T; Tagami T; Kuzuya H; Takahashi JA
    Endocr J; 2010; 57(6):551-3. PubMed ID: 20371983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.
    Beckers A; Stevenaert A; Foidart JM; Hennen G; Frankenne F
    J Clin Endocrinol Metab; 1990 Sep; 71(3):725-31. PubMed ID: 2118540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.
    Elias PC; Lugao HB; Pereira MC; Machado HR; Castro Md; Moreira AC
    Horm Metab Res; 2010 Jan; 42(1):50-5. PubMed ID: 19798623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and management of growth hormone excess in patients with McCune-Albright syndrome.
    Yao Y; Liu Y; Wang L; Deng K; Yang H; Lu L; Feng F; Xing B; You H; Jin Z; Wang R; Pan H; Chen S; Zhu H
    Eur J Endocrinol; 2017 Mar; 176(3):295-303. PubMed ID: 28007843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.